For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Key points On Jan. 20, 2025, the incoming United States administration froze all foreign assistance funds for 90 days, including the President’s Emergency Plan for AIDS Relief (PEPFAR) funding.[1][1] ...

Donald Trump’s America First Global Health Strategy has been largely welcomed by global health experts, but some have raised concerns over the practicalities of its implementation and gaps in its ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which is viewed as a key part of the drugmaker's growth strategy in HIV. The ...

Pride Month, typically observed annually in June, is a celebration of LGBTQIA+ diversity, equality, unity and freedom.1 A ...

Chronic respiratory diseases are among the top causes of death and disability worldwide, yet receive little political or ...

Introduction Male circumcision (MC) has been shown to decrease transmission of HIV and is a critical strategy to decrease its ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotatercept-csrk) versus placebo (both in ...

Correspondence to Professor Martin Schwellnus, Sport, Exercise Medicine and Lifestyle Institute (SEMLI) and Section Sports Medicine, University of Pretoria, Faculty of Health Sciences, Pretoria 0186, ...

Introduction Noma is a rapidly progressing, disfiguring orofacial necrotising infection that primarily affects children ...